Toxemia: all 933 studies

Page 8 of 10. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.

• Assessment of a Proposed Microbiological Alert and Its Impact on a Sepsis CampaignCompletedNCT02325258Not applicable
• Expression of TIM-3 on Lymphocytes in SepsisStatus unknownNCT02319876
• Dose Assessment of Melatonin in Sepsis TrialWithdrawnNCT02319265Phase 1/2
• the Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care UnitStatus unknownNCT02304224Not applicable
• Correlation Between PTP1B Expression and Organ Failure During SepsisCompletedNCT02295514Not applicable
• Relationship of Cerebral Perfusion Pressure Variability to Sepsis-associated EncephalopathyCompletedNCT02288715
• Epidemiology of Sepsis at Yuetan Subdistrict in BeijingStatus unknownNCT02285257
• Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial DatabaseCompletedNCT02281890
• A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset SepsisCompletedNCT02273843Phase 1
• Early Goal Directed Therapy in Sepsis by Emergency Medical ServicesWithdrawnNCT02266654Not applicable
• Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP TrialStatus unknownNCT02258984Not applicable
• Evaluation of CPD MNV as an Aid in the Diagnosis and Risk Assessment of Sepsis (Protocol # Sepsis 1-14)CompletedNCT02232750
• Causes and Factors Associated With Outcomes in Community-acquired Sepsis and Severe Sepsis in Northeast ThailandCompletedNCT02217592
• Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care UnitsCompletedNCT02213796Phase 4
• The Application of SERS and Metabolomics in SepsisStatus unknownNCT02213237
• Inferior Vena Cava Collapsibility Index in Severe SepsisStatus unknownNCT02195830Not applicable
• Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) StudyCompletedNCT02188992
• Effects of Subanesthetic Isoflurane/Sevoflurane in 60% Oxygen on Clinical In-vitro Experimental SepsisStatus unknownNCT02185118Not applicable
• Dynamic Changes of Tim-3 on Monocytes and Soluble Tim-3 in Patients With SepsisCompletedNCT02180009
• SHOCK US STUDY: Fluid Responsiveness in Sepsis Measured by UltrasonographyCompletedNCT02170233
• Jena Sepsis RegistryStatus unknownNCT02165501
• Pentoxifylline and Late Onset Sepsis in Preterm InfantsCompletedNCT02163174Phase 3
• Sepsis Trial of Early Physical Therapy Outside the ICUTerminatedNCT02159222Not applicable
• An Observational Study of the Causes, Management, and Outcomes of Community-acquired Sepsis and Severe Sepsis in Southeast AsiaCompletedNCT02157259
• Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in SepsisCompletedNCT02135770Phase 3
• Effect of Midazolam on Inflammatory Response and Organ Function in Mechanically Ventilated Sepsis Patients With Different Immune StatusStatus unknownNCT02135055Phase 4
• The Impact of Zinc Supplementation on Innate Immunity and Patient Safety in SepsisTerminatedNCT02130388Not applicable
• The Effect of Dexmedetomidine on Microcirculation in Severe SepsisTerminatedNCT02109965Phase 4
• Study to Evaluate the Effectiveness of the Initial Specimen Diversion Device When Collected Through Peripheral Intravenous CathetersTerminatedNCT02093494Not applicable
• Septic cArdiac Deficiency and MenIngococcal seveRe SepsisCompletedNCT02041663Not applicable
• Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Three, International Trials Comparing Protocolised With Usual Resuscitation in Patients Presenting to the Emergency Department With Severe Sepsis and Septic ShockCompletedNCT02030158
• Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe SepsisCompletedNCT02026856
• Prospective Study to Characterize Host-pathogen Related Factors in Hospitalized and ED Patients With LRTI and/or SepsisCompletedNCT02025699
• Efficacy of Mw Vaccine in Treatment of Severe SepsisCompletedNCT02025660Phase 2/3
• Prognostic Interest of Leucocyte Immunophenotyping During the Acute Phase of SepsisCompletedNCT01995448
• Angiotensin II Antagonist in Severe SepsisStatus unknownNCT01992796Phase 3
• Utility of High-Fidelity Simulation In the Education and Assessment of Residents in the Recognition and Management of the Sepsis SyndromeTerminatedNCT01992120Not applicable
• Prehospital Antibiotics Against Sepsis TrialCompletedNCT01988428Not applicable
• Validation of a Urinary Biomarker as Diagnostic Tool for AKI in SepsisCompletedNCT01981993
• The AVERT Sepsis InvestigationCompletedNCT01968746
• Lactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?CompletedNCT01964690
• Investigate the Activity of Endotoxin in Severe SepsisTerminatedNCT01957254
• International Multicentre Prevalence Study on SepsisCompletedNCT01943747
• German Lactat Clearance in Severe SepsisCompletedNCT01929772
• Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement TherapyWithdrawnNCT01926301
• Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome SequencingStatus unknownNCT01920217
• Outcomes of Severe Sepsis Patients in Surgical Intensive Care UnitsCompletedNCT01919138
• Molecular Diagnosis and Risk Stratification of SepsisStatus unknownNCT01905033
• The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular HealthStatus unknownNCT01888770
• Neonatal Suspected Sepsis Treated With Cefazolin or VancomycinCompletedNCT01867138Phase 3
• Efficacy of Melatonin in Patients With Severe Sepsis or Septic ShockStatus unknownNCT01858909Phase 3
• HSPA12B as a Potential Biomarker for Sepsis and Severe SepsisCompletedNCT01847248
• Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta SofaStatus unknownNCT01841190
• Oral Lactoferrin Supplementation for Prevention of Sepsis in Preterm NeonateStatus unknownNCT01821989Early Phase 1
• Amino Acids Expression Profiling of Patients With SepsisStatus unknownNCT01818830
• Lotta Alla Sepsi Ospedaliera - Fighting Hospital SepsisCompletedNCT01804764
• Methylene Blue in Severe Sepsis and Septic ShockStatus unknownNCT01797978Phase 3
• Early Physical Therapy in Patients With SepsisTerminatedNCT01787045Not applicable
• ASpirin for Patients With SEPsis and SeptIc ShockTerminatedNCT01784159Phase 2
• Dose-response Study of Arginine Supplementation in Severe SepsisCompletedNCT01775020Early Phase 1
• Dexmedetomidine for Sepsis in ICU Randomized Evaluation TrialCompletedNCT01760967Phase 4
• Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based ProjectCompletedNCT01751945Not applicable
• Study of the Function of Cells Involved in Inflammation in the Lungs of Those With Acute Lung Injury and SepsisCompletedNCT01725061
• Electronic Application of a Severe Sepsis Screening Tool and Management BundleStatus unknownNCT01724463
• Muscle Atrophy in Patients With Severe SepsisTerminatedNCT01717651
• EVLWI Exhibits Pulmonary and Systemic Permeability in Sepsis Related ALI/ARDSStatus unknownNCT01694147
• Sepsis in Neutropenic Patients: Autologous Stem Cell Transplantation as Model: a Transcriptomic ApproachStatus unknownNCT01693952Not applicable
• Simplified Severe Sepsis Protocol-2 (SSSP-2) in ZambiaCompletedNCT01663701Not applicable
• The Effects of Interferon-gamma on Sepsis-induced ImmunoparalysisCompletedNCT01649921Phase 3
• Sepsis MetabolomicsCompletedNCT01649440
• Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock PatientsWithdrawnNCT01601938Phase 2
• Understanding the Immune Response to Two Different Meningitis VaccinesCompletedNCT01593514Phase 4
• Procalcitonin in Cirrhotic Patients at High Risk for SepsisCompletedNCT01578226
• A Prospective Study of The Complement Depletion in Patients With Severe Abdominal SepsisCompletedNCT01568853Not applicable
• Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset SepsisCompletedNCT01551394Phase 3
• Hydralazine Versus Labetalol for the Management of Hypertensive Disorders of PregnancyCompletedNCT01538875Phase 3
• Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With SepsisStatus unknownNCT01535534
• Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal OriginCompletedNCT01530932
• Lactoferrin for Prevention of Sepsis in InfantsCompletedNCT01525316Phase 3
• Procalcitonin Monitoring Sepsis StudyCompletedNCT01523717
• Comparing an Automated to a Conventional Sepsis Clinical Prediction RuleWithdrawnNCT01505478
• Association Between cd163 Gene Polymorphisms and Sepsis Among Chinese Han PopulationStatus unknownNCT01504243
• The Impact of Continuous Renal Replacement Therapy on the Outcomes of Burn Patients With Early Phase of SepsisStatus unknownNCT01501097Not applicable
• Urinary Proteomics Analysis for Sepsis and PrognosisStatus unknownNCT01493492
• Serum Proteomics Analysis for SepsisStatus unknownNCT01493466
• Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe SepsisStatus unknownNCT01486524
• Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe SepsisCompletedNCT01484106Not applicable
• MiRNAs Evaluate the Prognosis of Sepsis by Dynamic StudyStatus unknownNCT01459822
• Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis TrialCompletedNCT01453270Not applicable
• Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for CesareanWithdrawnNCT01451060Phase 3
• Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.CompletedNCT01450358Phase 4
• Simplified Severe Sepsis Protocol in ZambiaTerminatedNCT01449916Not applicable
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
• Critical Care Excellence in Sepsis and TraumaCompletedNCT01426711
• Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.CompletedNCT01411670Phase 2
• The Value of sTREM-1, PCT, and CRP as Markers for the Detection of Sepsis and Bacteremia Among Patients With a FUOCompletedNCT01410578
• Assessment of Peritoneal Immune Response in Patients With Severe Intra-abdominal Sepsis Managed With Laparostomy and Vacuum Assisted Closure (VAC)CompletedNCT01410526
• Sepsis Institutional Registry in Hospital Italiano de Buenos AiresCompletedNCT01403935
• Peripheral Perfusion Targeted Fluid ManagementStatus unknownNCT01397474Phase 4
• IMproved PREdiction of Severe Sepsis in the Emergency DepartmentCompletedNCT01392508

← Toxemia overview